NLRP6 and metastatic malignant neoplasm in the lymph nodes: Here, we show that NLRP6 was down-regulated in approximately 75% of primary gastric cancer cases and exhibited significant associations with advanced clinical-stage lymph node metastasis and poor overall survival.